Press Releases - Spark Newswire

3 minute read

Grove Inc. Launches Amazon Aggregation Division

Today, 4:06 PM

Upexi Unit Created to Acquire and Scale Promising Ecommerce Businesses HENDERSON, NV / October 14, 2021 / Grove, Inc. (NASDAQ: GRVI) ("Grove" or the "Company"), a global innovator in hemp, health, and wellness, today announced the launch of

GRVI

6 minute read

The Drone Racing League and Draganfly Launch Multi-Year Partnership and Innovation Lab

By DraganFly

Today, 4:06 PM

Draganfly, a global UAV leader, partners with DRL to advance drone racing and humanitarian aid through new groundbreaking technology

CSE:DPRO

4 minute read

WELLTEQ DIGITAL HEALTH INC. EXTENDS PRIVATE HEALTH INSURER PARTNERSHIP FOR 3-YEARS

By Wellteq

Today, 4:06 PM

Wellteq Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) has extended its agreement with Australia’s fourth largest private health insurer through a three-year Service Agreement.

CSE:WTEQ

3 minute read

How Stage 32 Is Helping Filmmakers Navigate Changes In The Entertainment Industry

By Elizabeth Walker

Today, 4:06 PM

The pandemic changed the way we view and consume entertainment. In 2020, movie theaters and concert venues shut down worldwide, causing an abrupt pause in releases and revenue. The pandemic’s disruption of the film industry left many without work or paychecks for months on end. But once things began to open up and people resumed filming, things accelerated like never before.

NFLX

4 minute read

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans

By Hoth Therapeutics

Today, 4:06 PM

NEW YORK, NY October 12, 2020 / PR Newswire / Hoth Therapeutics, Inc.

HOTH

5 minute read

Draganfly Signs $9 Million Exclusive Manufacturing Agreement with Digital Dream Labs

By DraganFly

Today, 4:06 PM

Los Angeles, CA. October 12, 2021 -- Draganfly Inc.

CSE:DPRO

6 minute read

NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity

By NanoViricides

Today, 4:06 PM

Shelton, Connecticut -- (October 11, 2021) - NanoViricides, Inc.

NNVC

4 minute read

Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

By Pasithea

Today, 4:06 PM

-- Company contracts leading global drug development company to advance initial drug candidate --

KTTA

2 minute read

Phunware Holds Fireside Chat with Grasso Global Capital CEO Steve Grasso

By Phunware

Today, 4:06 PM

AUSTIN, Texas (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”), a fully-

PHUN

8 minute read

NOUVEAU MONDE COMMISSIONS STATE-OF-THE-ART LABORATORY TO FURTHER ITS PROPRIETARY BATTERY TECHNOLOGY RESEARCH AND DEVELOPMENT; HIRES NEW SENIOR SCIENTISTS

By Nouveau Monde

Today, 4:06 PM

M.V. Reddy, PhD, Senior Professional Researcher, Martin Brassard, PhD, R&D Director, and Neel Rahem, Laboratory Manager, work in Nouveau Monde’s new lab facilities.

NMG